Glycobiology, 1999, Vol. 9, No. 12 1307-1311
© 1999 Oxford University Press
An
2,3sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas
Imperial Cancer Research Fund Breast Cancer Biology Groupand 3Hedley Atkins/ICRFBreast Pathology, Guys Hospital, London SE1 9RT, UK, 4In situ HybridizationService and Histopathology Unit, Imperial Cancer Research Fund,44 Lincolns Inn Fields, London WC2A 3PX, UK, 5Department of Oral Diagnostics,School of Dentistry, University of Copenhagen, DK2200 Copenhagen,Denmark
The MUC1 mucin is expressed on the luminal surfaceof most simple epithelial cells but in carcinomas, especially thoseof the breast and ovary, MUC1 is upregulated and aberrantly glycosylated.MUC1 contains a large amount of O-linked glycans which, in the mucinexpressed by normal mammary epithelial cells, consist mainly ofcore 2 based structures carrying polylactosamine chains. However,the mucin expressed by breast carcinomas has shorter side-chains, oftenconsisting of sialylated core 1 (Galß13GalNAc). in situ hybridization of primary breasttissue showed that a sialyltransferase (ST3Gal I), responsible foradding sialic acid to core 1 thereby terminating chain extension,is elevated in primary breast carcinomas when compared to normalor benign tissue. Furthermore, the level of mRNA expression encodingST3Gal I is correlated to the intensity of staining seen with theantibody SM3, which specifically recognises underglycosylated, tumourassociated MUC1. Thus, the aberrant glycosylation of MUC1 seen inbreast carcinomas appears to be due, at least in part, to the elevationof ST3Gal I.
a Correspondenceto: Dr Joy Burchell, ICRF Breast Cancer Biology Group, 3rd Floor,Thomas Guy House, Guys Hospital, London SE1 9RT, UK
b Presentaddress: Cancer Genetics Laboratory, 8th Floor, Guys Tower, Guys Hospital, London SE1 9RT, UK
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Yue, I. J. Goldstein, M. A. Hollingsworth, K. Kaul, R. E. Brand, and B. B. Haab The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Lectin Sandwich Arrays Mol. Cell. Proteomics, July 1, 2009; 8(7): 1697 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sihlbom, I. van Dijk Hard, M. E Lidell, T. Noll, G. C Hansson, and M. Backstrom Localization of O-glycans in MUC1 glycoproteins using electron-capture dissociation fragmentation mass spectrometry Glycobiology, April 1, 2009; 19(4): 375 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wilkie, G. Picco, J. Foster, D. M. Davies, S. Julien, L. Cooper, S. Arif, S. J. Mather, J. Taylor-Papadimitriou, J. M. Burchell, et al. Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor J. Immunol., April 1, 2008; 180(7): 4901 - 4909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Julien, M. J. Grimshaw, M. Sutton-Smith, J. Coleman, H. R. Morris, A. Dell, J. Taylor-Papadimitriou, and J. M. Burchell Sialyl-Lewisx on P-Selectin Glycoprotein Ligand-1 Is Regulated during Differentiation and Maturation of Dendritic Cells: A Mechanism Involving the Glycosyltransferases C2GnT1 and ST3Gal I J. Immunol., November 1, 2007; 179(9): 5701 - 5710. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Valencia, F. Rouzaud, S. Julien, K. G. Chen, T. Passeron, Y. Yamaguchi, M. Abu-Asab, M. Tsokos, G. E. Costin, H. Yamaguchi, et al. Sialylated Core 1 O-Glycans Influence the Sorting of Pmel17/gp100 and Determine Its Capacity to Form Fibrils J. Biol. Chem., April 13, 2007; 282(15): 11266 - 11280. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Yu, N. Andrews, Q. Zhao, D. McKean, J. F. Williams, L. J. Connor, O. V. Gerasimenko, J. Hilkens, J. Hirabayashi, K. Kasai, et al. Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion J. Biol. Chem., January 5, 2007; 282(1): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sewell, M. Backstrom, M. Dalziel, S. Gschmeissner, H. Karlsson, T. Noll, J. Gatgens, H. Clausen, G. C. Hansson, J. Burchell, et al. The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer J. Biol. Chem., February 10, 2006; 281(6): 3586 - 3594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sorensen, C. A. Reis, M. A. Tarp, U. Mandel, K. Ramachandran, V. Sankaranarayanan, T. Schwientek, R. Graham, J. Taylor-Papadimitriou, M. A. Hollingsworth, et al. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance Glycobiology, February 1, 2006; 16(2): 96 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rughetti, I. Pellicciotta, M. Biffoni, M. Backstrom, T. Link, E. P. Bennet, H. Clausen, T. Noll, G. C. Hansson, J. M. Burchell, et al. Recombinant Tumor-Associated MUC1 Glycoprotein Impairs the Differentiation and Function of Dendritic Cells J. Immunol., June 15, 2005; 174(12): 7764 - 7772. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Olson, M. Backstrom, H. Karlsson, J. Burchell, and G. C. Hansson A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase Glycobiology, February 1, 2005; 15(2): 177 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Lee, H. G. Kim, M. R. Hwang, J. I. Chae, J. M. Yang, Y. C. Lee, Y. K. Choo, Y. I. Lee, S.-S. Lee, and S.-I. Do The Hexapeptide Inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-Sialyltransferase as a Generic Inhibitor of Sialyltransferases J. Biol. Chem., December 13, 2002; 277(51): 49341 - 49351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muller and F.-G. Hanisch Recombinant MUC1 Probe Authentically Reflects Cell-specific O-Glycosylation Profiles of Endogenous Breast Cancer Mucin. HIGH DENSITY AND PREVALENT CORE 2-BASED GLYCOSYLATION J. Biol. Chem., July 12, 2002; 277(29): 26103 - 26112. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Machida, J. Nakayama, J. Amano, and M. Fukuda Clinicopathological Significance of Core 2 {beta}1,6-N-Acetylglucosaminyltransferase Messenger RNA Expressed in the Pulmonary Adenocarcinoma Determined by in Situ Hybridization Cancer Res., March 1, 2001; 61(5): 2226 - 2231. [Abstract] [Full Text] |
||||
![]() |
M. Dalziel, C. Whitehouse, I. McFarlane, I. Brockhausen, S. Gschmeissner, T. Schwientek, H. Clausen, J. M. Burchell, and J. Taylor-Papadimitriou The Relative Activities of the C2GnT1 and ST3Gal-I Glycosyltransferases Determine O-Glycan Structure and Expression of a Tumor-associated Epitope on MUC1 J. Biol. Chem., March 30, 2001; 276(14): 11007 - 11015. [Abstract] [Full Text] [PDF] |
||||




